BCIQ Profiles

Company Profile Report
DIST_0407_scitranslmed.abf1587

Blocking SERPINB13 for Type I diabetes

Apr 29, 2021 | 10:02 PM GMT

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Diabetes

Antibodies against SERPINB13, a protease inhibitor expressed in

Read the full 207 word article

How to gain access

Continue reading with a
two-week free trial.